Back to search
FDAFDA · Food and drugs·Recall number D-0807-2020

Liothyronine (T3) 80 mcg SR cap

Published February 5, 2020 · Recall initiated: December 18, 2019

Summary

FDA records drug Class II recall D-0807-2020, published February 5, 2020 and initiated December 18, 2019. Recalling firm: MPRX, Inc. dba Medical Park Pharmacy; Status: Terminated; Reported quantity: 5 bottles; Lot: Lot: 61253:42 Use by: 04/01/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
MPRX, Inc. dba Medical Park Pharmacy
Distributor
TX
Lot
Lot: 61253:42 Use by: 04/01/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Liothyronine (T3) 80 mcg SR cap recalled?

Yes. FDA published recall D-0807-2020 on February 5, 2020. Reported hazard: Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

What should I do if I have this product?

Voluntary: Firm initiated · Letter